We are international
Donate
• about myeloma TEXT SIZE   
publications    back

Myeloma Minute
May 2, 2013
05.02.13
May 2, 2013
Share the Minute Facebook Tweet!
Clinical Trials
Donate to the IMF
 




Upcoming Events





May 10-11, 2013
San Francisco/Bay Area Patient & Family Seminar
Redwood City, California





Saturday, May 18, 2013
Grand Rapids Regional Community Workshop
Grand Rapids, Michigan




Saturday, June 15, 2013
Minneapolis Regional Community Workshop
St. Louis Park, Minnesota




When You Shop at the IMF Mall,
You Support the IMF! Thanks!
Brian Durie, MD, Discusses Diet and Cancer in BBC Radio Interview
Dr. Brian Durie, Chairman and Co-Founder of the IMF, discussed the relationship between diet and cancer this week for an upcoming edition of "The Food Programme" on BBC Radio 4. In his blog, Dr. Durie shares his conversation with veteran U.K. food journalist Sheila Dillon on what science demonstrates are foods to be avoided. "What a cancer patient doesn't eat," he said, "is more important than what a cancer patient does eat." READ MORE

x
 
Daratumumab Receives Breakthrough Therapy Designation in Myeloma
The U.S. Food and Drug Administration (FDA) has granted daratumumab breakthrough therapy designation for the treatment of patients with multiple myeloma who have received at least three prior lines of therapy. According to the FDA, breakthrough therapy designation is intended to expedite the development and review time for a potential new medicine "to treat a serious or life-threatening disease or condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development." ANNOUNCEMENT | FDA FAQ: BREAKTHROUGH THERAPIES

x
7 Newly Updated Myeloma Publications Now Available in Spanish
The IMF has translated seven recently updated myeloma publications into Spanish. The Spanish-language publications, which include the "IMF Patient Handbook", "Understanding Bisphosphonate Therapy," "Understanding High-Dose Therapy with Stem Cell Rescue," "Understanding KYPROLIS® (carfilzomib)," "Understanding POMALYST® (pomalidomide)," "Understanding REVLIMID® (lenalidomide)," and "Understanding VELCADE® (bortezomib)" are available online and in print. To receive a print version, please email TheIMF@myeloma.org.READ MORE

x
The Patients Equal Access Coalition Applauds New Bill to Improve Access to Oral Cancer Drugs
The Patients Equal Access Coalition (PEAC), which is led by the International Myeloma Foundation, commends Congressman Brian Higgins (NY-26th District) on the introduction of the Cancer Drug Coverage Parity Act, H.R. 1801, into Congress on April 26. This federal bill is a critical step toward improving access to anticancer treatments by requiring insurance companies to cover patient-administered and physician-administered anticancer drugs at the same cost to patients. READ MORE

x
Golf Fundraiser Honors Memory of Former IMF Board Member
The guidance and expertise that former IMF Board member Rich Saletan brought to the IMF spurred tremendous growth of the organization. To continue Rich's mission to find a cure for multiple myeloma, his family and friends started the annual RHS Open fundraiser. The 2nd annual RHS Open will be held this Saturday, May 4th, at the Wycliffe Country Club in Wellington, Florida. Can't be there in person? You can participate virtually by sponsoring a hole at the open. REGISTRATION AND INFORMATION



Join Our Mailing List

 
12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
IMF Hotline: 800-452-2873 or 818-487-7455
Privacy Policy | Unsubscribe 
www.myeloma.org
=
 related articles